ES2118650T3 - Derivados de la quinolina-4-carbonilguanidina, procedimiento para la preparacion de los mismos y preparaciones farmaceuticas que contienen los compuestos. - Google Patents
Derivados de la quinolina-4-carbonilguanidina, procedimiento para la preparacion de los mismos y preparaciones farmaceuticas que contienen los compuestos.Info
- Publication number
- ES2118650T3 ES2118650T3 ES96101831T ES96101831T ES2118650T3 ES 2118650 T3 ES2118650 T3 ES 2118650T3 ES 96101831 T ES96101831 T ES 96101831T ES 96101831 T ES96101831 T ES 96101831T ES 2118650 T3 ES2118650 T3 ES 2118650T3
- Authority
- ES
- Spain
- Prior art keywords
- quinoline
- compounds
- same
- carbonylguanidine
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- QRLLPNRPIVYGSJ-UHFFFAOYSA-N n-(diaminomethylidene)quinoline-4-carboxamide Chemical class C1=CC=C2C(C(=O)NC(=N)N)=CC=NC2=C1 QRLLPNRPIVYGSJ-UHFFFAOYSA-N 0.000 title abstract 2
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 229940039227 diagnostic agent Drugs 0.000 abstract 1
- 239000000032 diagnostic agent Substances 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/50—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4
- C07D215/52—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4 with aryl radicals attached in position 2
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
LA INVENCION SE REFIERE A UN DERIVADO DE LA QUINOLINA-4CARBONILGUANIDINA REPRESENTANDO POR LA FORMULA (I) Y A LAS SALES FARMACOLOGICAMENTE ACEPTABLES DEL MISMO, A UN PROCEDIMIENTO PARA PRODUCIR EL MISMO, Y A UN INHIBIDOR DEL INTERCAMBIADOR DEL NA{SUP,+}/H{SUP,+} QUE CONTIENE EL COMPUESTO COMO INGREDIENTE ACTIVO. LOS COMPUESTOS DE LA INVENCION SON UTILES COMO AGENTES PARA EL TRATAMIENTO O PREVENCION DE DIFERENTES ENFERMEDADES PRODUCIDAS POR LA HIPERFUNCION DEL INTERCAMBIADOR DE NA{SUP,+}/H{SUP,+} Y COMO AGENTES DE DIAGNOSTICO PARA ESTAS ENFERMEDADES.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2176595 | 1995-02-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2118650T3 true ES2118650T3 (es) | 1998-09-16 |
Family
ID=12064172
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES96101831T Expired - Lifetime ES2118650T3 (es) | 1995-02-09 | 1996-02-08 | Derivados de la quinolina-4-carbonilguanidina, procedimiento para la preparacion de los mismos y preparaciones farmaceuticas que contienen los compuestos. |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US5627193A (es) |
| EP (1) | EP0726254B1 (es) |
| AT (1) | ATE165822T1 (es) |
| DE (1) | DE69600272T2 (es) |
| ES (1) | ES2118650T3 (es) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ314105A (en) * | 1996-02-02 | 1997-12-19 | Sumitomo Pharma | Guanidine derivative substituted with a substituted indole which is peri condensed with a heterocyclic ring |
| JPH09291076A (ja) * | 1996-04-24 | 1997-11-11 | Sumitomo Pharmaceut Co Ltd | 置換グアニジン誘導体およびその製法 |
| AP1201A (en) * | 1997-09-17 | 2003-09-01 | Smithkline Beecham Corp | Method for the synthesis of quinoline derivatives. |
| AUPQ223999A0 (en) * | 1999-08-16 | 1999-09-09 | University Of Sydney, The | Intracellular feedback controls in the diagnosis and treatment of human disease |
| JP4299144B2 (ja) * | 2001-12-26 | 2009-07-22 | イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー | フッ素化フェニルピリジン、フェニルピリミジン、およびフェニルキノリンを含むエレクトロルミネッセンスイリジウム化合物ならびにこのような化合物を用いて製造されるデバイス |
| DE10206358A1 (de) * | 2002-02-14 | 2003-08-28 | Aventis Pharma Gmbh | Verwendung von Inhibitoren des Natrium-Wasserstoff-Austauschers zur Behandlung von thrombotischer und inflammatorischer Erkrankungen |
| KR100518184B1 (ko) * | 2003-12-27 | 2005-10-04 | 한국화학연구원 | 퓨란카보닐구아니딘 유도체, 그의 제조방법 및 그를포함하는 약학적 조성물 |
| JP5634985B2 (ja) | 2008-05-09 | 2014-12-03 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung | インスリン抵抗性およびβ−細胞機能障害に関連する疾患を治療するためのリメポリドを含む医薬組成物 |
| US20120214803A1 (en) | 2011-02-18 | 2012-08-23 | Vifor (International) Ag | Novel Sulfonaminoquinoline Hepcidin Antagonists |
| CN102417479B (zh) * | 2011-08-29 | 2014-02-26 | 南京大学 | Stat3小分子选择性抑制剂及其制备方法和应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2538388B1 (fr) * | 1982-12-24 | 1985-06-21 | Pharmuka Lab | Nouveaux derives de naphtalene- ou azanaphtalenecarboxamide, leurs procedes de preparation et leur utilisation comme medicaments |
| JPS59189633A (ja) * | 1983-04-13 | 1984-10-27 | Fujitsu Ltd | 半導体装置の製造方法 |
| US4680299A (en) * | 1984-04-30 | 1987-07-14 | E.I. Du Pont De Nemours And Company | 2-phenyl-4-quinolinecarboxylic acids and pharmaceutical compositions thereof |
| JPS63119455A (ja) * | 1986-06-27 | 1988-05-24 | Nippon Shinyaku Co Ltd | グリシン誘導体 |
| DE3905339A1 (de) * | 1989-02-22 | 1990-09-06 | Basf Ag | Chinolin-4-carbonsaeurederivate und deren verwendung |
| DE3929582A1 (de) * | 1989-09-06 | 1991-03-07 | Hoechst Ag | Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament |
| US5204329A (en) * | 1990-06-11 | 1993-04-20 | Du Pont Merck Pharmaceutical Company | Treatment of organ transplantation rejection |
| DK0556674T3 (da) * | 1992-02-15 | 1996-10-14 | Hoechst Ag | 3,5-Substituerede benzoylguanidiner med antiarytmisk virkning og inhiberende virkning på celleproliferation |
| DK0590455T3 (da) * | 1992-09-28 | 2001-01-22 | Hoechst Ag | Antiarrytmiske og cardioprotektive substiuerede 1(2H)-isoquinoliner, fremgangsmåde til deres fremstilling, lægemiddel indeh |
| CA2121391A1 (en) * | 1993-04-28 | 1994-10-29 | Atsuyuki Kojima | Indoloylguanidine derivatives |
| IL109570A0 (en) * | 1993-05-17 | 1994-08-26 | Fujisawa Pharmaceutical Co | Guanidine derivatives, pharmaceutical compositions containing the same and processes for the preparation thereof |
| DE4415873A1 (de) * | 1994-05-05 | 1995-11-09 | Hoechst Ag | Substituierte bizyklische Heteroaroylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
-
1996
- 1996-01-31 US US08/594,789 patent/US5627193A/en not_active Expired - Fee Related
- 1996-02-08 ES ES96101831T patent/ES2118650T3/es not_active Expired - Lifetime
- 1996-02-08 EP EP96101831A patent/EP0726254B1/en not_active Expired - Lifetime
- 1996-02-08 DE DE69600272T patent/DE69600272T2/de not_active Expired - Fee Related
- 1996-02-08 AT AT96101831T patent/ATE165822T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE69600272T2 (de) | 1998-09-17 |
| ATE165822T1 (de) | 1998-05-15 |
| EP0726254A1 (en) | 1996-08-14 |
| DE69600272D1 (de) | 1998-06-10 |
| EP0726254B1 (en) | 1998-05-06 |
| US5627193A (en) | 1997-05-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT92806A (pt) | Processo para a preparacao de derivados de 2-amino-pirimidinona e de composicoes farmaceuticas que os contem | |
| DE69528005D1 (de) | Prolineamid-Derivate | |
| NO974163L (no) | Ester av 5-aminolevulinsyre som fotosensibiliserings-middel i fotokjemoterapi | |
| ES2018111A6 (es) | Procedimiento de preparacion de derivados de 4h-1-benzopiran-4-ona o sus sales. | |
| MY113733A (en) | Salts of an anti-migraine indole derivative | |
| ATE226574T1 (de) | 4,6-diarylpyrimidin-derivate und deren salze | |
| LU91943I2 (fr) | Tafluprost et ses dérivés pharmaceutiquement acceptables (SAFLUTAN®) | |
| DE69021755D1 (de) | Benzopyranderivate und Verfahren zu ihrer Herstellung. | |
| BR9807079A (pt) | Composto de derivado de 16-hidróxi-11- (fenil substituìdo) - estra-4,9-dieno, uso de um composto, formulação farmacêutica, e processo para a preparação de um composto. | |
| ES552593A0 (es) | Un procedimiento para preparar derivados de aminoacidos | |
| CA2124455A1 (en) | Indole derivatives, process for producing the same and medicinal uses of the same | |
| ES2118650T3 (es) | Derivados de la quinolina-4-carbonilguanidina, procedimiento para la preparacion de los mismos y preparaciones farmaceuticas que contienen los compuestos. | |
| PT82512A (fr) | Procede de preparation de derives de quinolylglycinamides ayant activite psychotrope et de compositions pharmaceutiques les contenant | |
| ES528561A0 (es) | Un procedimiento para la preparacion de compuestos nitro alifaticos | |
| PT91203A (pt) | Processo para a preparacao de novos derivados de antibioticos bu-3608 e de composicoes farmaceuticas que os contem | |
| ES2055235T3 (es) | Composicion anti-inflamatoria y/o antialergica que comprende derivados de glutation. | |
| HUT64318A (en) | Process for production benzodpyrane derivativs and pharmaceutical preparations containing these compounds as effective substance | |
| DE69330601D1 (de) | Serotoninergische ergolin derivate | |
| BR9502079A (pt) | Composto,formulação farmaceutica e processo para preparar um composto | |
| ES528462A0 (es) | Procedimiento de preparacion de nuevos derivados dialquilaminoalcoxibencilalcoholicos y de sus sales de adicion acidas y amonicas cuaternarias | |
| BR9305752A (pt) | Composto composiçao farmaceutica e processo para a preparaçao de um composto de derivados alquila da trazodona | |
| SE8903312D0 (sv) | New 2-carbonyl substituted n,n'-di-(trimethoxybenzol)piperazines, process for preparing the same and therapeutical compounds containing them | |
| SE9004039D0 (sv) | 3-(n-metyl-n-alkyl)-amino-2-metoximetylen-propan-1-ol-derivat, ett framstaellningsfoerfarande foer desamma samt terapeutiska kompositioner innehaallande dem | |
| MA21913A1 (fr) | Procede de preparation de derives amino-oligohydroxy inhibiteurs de la renine . | |
| SE8903313D0 (sv) | New 2-methoxycarbonyl substituted n,n'-di(trimethoxybenzol) piperazines, process for preparing the same and therapeutical compounds compounds containing |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 726254 Country of ref document: ES |